Skip to main content
Erschienen in: Journal of Thrombosis and Thrombolysis 1/2009

01.07.2009

Acute in-vivo evaluation of bleeding with GelfoamTM plus saline and Gelfoam plus human thrombin using a liver square lesion model in swine

verfasst von: George L. Adams, Roberto J. Manson, Vic Hasselblad, Linda K. Shaw, Jeffrey H. Lawson

Erschienen in: Journal of Thrombosis and Thrombolysis | Ausgabe 1/2009

Einloggen, um Zugang zu erhalten

Abstract

Background Management of post-operative bleeding has historically used topical bovine thrombin. However, possible harm through activation of coagulation inhibitors has encouraged investigation with other hemostatic agents. This study utilized a novel ordinal bleeding model to test whether a Gelfoam + human thrombin solution is superior at controlling bleeding when compared to Gelfoam + saline solution at different time intervals. Study design Four swine underwent open laparotomy after receiving unfractionated heparin. Twenty open liver biopsies were performed in each swine; ten biopsies treated with Gelfoam + human thrombin solution and 10 biopsies treated with Gelfoam + saline solution. Three, 6 min, and 12 min after the procedure, bleeding was objectively graded by a four-point model. Results There was a significant (P < 0.017), treatment effect on each success/failure outcome (success = bleeding score ≤ 1; failure = bleeding score > 1) at 3 (P < 0.001), 6 (P < 0.001), and 12 (P = 0.003) min, based on a 2 × 2 Fisher’s exact test. Similarly, there was a significant treatment effect on each success/failure outcome and four-point bleeding score based on a multiple logistic regression analysis controlling for pig, lesion weight, and initial bleeding taking into consideration repeated measures at three time points. Conclusions The results demonstrate a superior treatment effect for control of bleeding using human thrombin compared to a saline solution. Future studies should compare bovine thrombin versus human thrombins ability to control bleeding as well as the hazard of each in activating coagulation inhibitors.
Literatur
1.
Zurück zum Zitat Seegers WH, Warner ED, Brinkhous KM, Smith HP (1939) The use of purified thrombin as an hemostatic agent. Science 89:85–86CrossRef Seegers WH, Warner ED, Brinkhous KM, Smith HP (1939) The use of purified thrombin as an hemostatic agent. Science 89:85–86CrossRef
2.
Zurück zum Zitat Ofodile FA, Sadana MK (1991) The role of topical thrombin in skin grafting. J Natl Med Assoc 83(5):416–418PubMed Ofodile FA, Sadana MK (1991) The role of topical thrombin in skin grafting. J Natl Med Assoc 83(5):416–418PubMed
3.
Zurück zum Zitat Sawada Y, Yotsuyanagi T (1992) A technique of haemostasis of the extremities after debridement of burn wounds. Burns 18(5):412–415PubMedCrossRef Sawada Y, Yotsuyanagi T (1992) A technique of haemostasis of the extremities after debridement of burn wounds. Burns 18(5):412–415PubMedCrossRef
4.
Zurück zum Zitat Kruger K, Zahringer M, Sohngen FD, Gossmann A, Schulte O, Feldmann C, Strohe D, Lackner K (2003) Femoral pseudoaneurysms: management with percutaneous thrombin injections—success rates and effects on systemic coagulation. Radiology 226(2):452–458PubMedCrossRef Kruger K, Zahringer M, Sohngen FD, Gossmann A, Schulte O, Feldmann C, Strohe D, Lackner K (2003) Femoral pseudoaneurysms: management with percutaneous thrombin injections—success rates and effects on systemic coagulation. Radiology 226(2):452–458PubMedCrossRef
5.
Zurück zum Zitat Strickler RB, Lane PK, Leffert JD, Rodgers GM, Shuman MA, Corash L (1989) Development of antithrombin antibodies following surgery in patients with prosthetic cardiac valves. Blood 73:1375–1380 Strickler RB, Lane PK, Leffert JD, Rodgers GM, Shuman MA, Corash L (1989) Development of antithrombin antibodies following surgery in patients with prosthetic cardiac valves. Blood 73:1375–1380
6.
Zurück zum Zitat Flaherty MJ, Henderson R, Wener MH (1989) Iatrogenic immunization with bovine thrombin: a mechanism for prolonged thrombin times after surgery. Ann Intern Med 111:631–634PubMed Flaherty MJ, Henderson R, Wener MH (1989) Iatrogenic immunization with bovine thrombin: a mechanism for prolonged thrombin times after surgery. Ann Intern Med 111:631–634PubMed
7.
Zurück zum Zitat Ortel TL, Mercer MC, Thames EH, Moore KD, Lawson JH (2000) Immunologic impact and clinical outcomes after surgical exposure to bovine thrombin. Ann Surg 233:88–96CrossRef Ortel TL, Mercer MC, Thames EH, Moore KD, Lawson JH (2000) Immunologic impact and clinical outcomes after surgical exposure to bovine thrombin. Ann Surg 233:88–96CrossRef
8.
Zurück zum Zitat Turner AS, Parker D, Egbert B, Maroney M, Armstrong R, Powers N (2002) Evaluation of a novel hemostatic device in an ovine parenchymal organ bleeding model of normal and impaired hemostasis. J Biomed Mater Res 63(1):37–47PubMedCrossRef Turner AS, Parker D, Egbert B, Maroney M, Armstrong R, Powers N (2002) Evaluation of a novel hemostatic device in an ovine parenchymal organ bleeding model of normal and impaired hemostasis. J Biomed Mater Res 63(1):37–47PubMedCrossRef
9.
Zurück zum Zitat Schelling G, Block T, Blancke E, Hammer C, Brendel W, Gokel M (1987) The effectiveness of a fibrinogen–thrombin–collagen-based hemostatic agent in an experimental arterial bleeding model. Ann Surg 205(4):432–435PubMedCrossRef Schelling G, Block T, Blancke E, Hammer C, Brendel W, Gokel M (1987) The effectiveness of a fibrinogen–thrombin–collagen-based hemostatic agent in an experimental arterial bleeding model. Ann Surg 205(4):432–435PubMedCrossRef
10.
Zurück zum Zitat Wiseman DM, Gottlick LE, Diamond MP (1992) Effect of thrombin induced hemostasis on the efficacy of an absorbable adhesion barrier. J Reprod Med 37(9):766–770PubMed Wiseman DM, Gottlick LE, Diamond MP (1992) Effect of thrombin induced hemostasis on the efficacy of an absorbable adhesion barrier. J Reprod Med 37(9):766–770PubMed
11.
Zurück zum Zitat SAS Institute Inc., SAS/STAT Users Guide, Version 8. SAS, Cary, NC SAS Institute Inc., SAS/STAT Users Guide, Version 8. SAS, Cary, NC
12.
Zurück zum Zitat Ortel TL, Charles LA, Keller FG, Marcom PK, Oldham HN Jr, Kane WH, Macik BG (1994) Topical thrombin and acquired coagulation factor inhibitors: clinical spectrum and laboratory diagnosis. Am J Hematol 45(2):128–135PubMedCrossRef Ortel TL, Charles LA, Keller FG, Marcom PK, Oldham HN Jr, Kane WH, Macik BG (1994) Topical thrombin and acquired coagulation factor inhibitors: clinical spectrum and laboratory diagnosis. Am J Hematol 45(2):128–135PubMedCrossRef
13.
Zurück zum Zitat Lundblad RL, Bradshaw RA, Gabriel D, Ortel TL, Lawson J, Mann KG (2004) A review of the therapeutic uses of thrombin. Thromb Haemost 91(5):851–860PubMed Lundblad RL, Bradshaw RA, Gabriel D, Ortel TL, Lawson J, Mann KG (2004) A review of the therapeutic uses of thrombin. Thromb Haemost 91(5):851–860PubMed
Metadaten
Titel
Acute in-vivo evaluation of bleeding with GelfoamTM plus saline and Gelfoam plus human thrombin using a liver square lesion model in swine
verfasst von
George L. Adams
Roberto J. Manson
Vic Hasselblad
Linda K. Shaw
Jeffrey H. Lawson
Publikationsdatum
01.07.2009
Verlag
Springer US
Erschienen in
Journal of Thrombosis and Thrombolysis / Ausgabe 1/2009
Print ISSN: 0929-5305
Elektronische ISSN: 1573-742X
DOI
https://doi.org/10.1007/s11239-008-0249-3

Weitere Artikel der Ausgabe 1/2009

Journal of Thrombosis and Thrombolysis 1/2009 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

CAR-M-Zellen: Warten auf das große Fressen

22.05.2024 Onkologische Immuntherapie Nachrichten

Auch myeloide Immunzellen lassen sich mit chimären Antigenrezeptoren gegen Tumoren ausstatten. Solche CAR-Fresszell-Therapien werden jetzt für solide Tumoren entwickelt. Künftig soll dieser Prozess nicht mehr ex vivo, sondern per mRNA im Körper der Betroffenen erfolgen.

Chronische Verstopfung: „Versuchen Sie es mit grünen Kiwis!“

22.05.2024 Obstipation Nachrichten

Bei chronischer Verstopfung wirken Kiwis offenbar besser als Flohsamenschalen. Das zeigen die Daten aus einer randomisierten Studie, die der Gastroenterologe Oliver Pech beim Praxis-Update vorstellte.

So häufig greift rheumatoide Arthritis auf Organe über

21.05.2024 Rheumatoide Arthritis Nachrichten

Im Verlauf von rheumatoider Arthritis entwickeln viele Patienten extraartikuläre Manifestationen. Schwedische Forscher haben sich mit der Inzidenz und den Risikofaktoren befasst.

Blutdrucksenkung könnte Uterusmyome verhindern

Frauen mit unbehandelter oder neu auftretender Hypertonie haben ein deutlich erhöhtes Risiko für Uterusmyome. Eine Therapie mit Antihypertensiva geht hingegen mit einer verringerten Inzidenz der gutartigen Tumoren einher.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.